Specific antibody response of mice after immunization with COS-7 cell derived avian influenza virus (H5N1) recombinant proteins
2007

Mice Antibody Response to Avian Influenza Vaccine

Sample size: 25 publication 10 minutes Evidence: moderate

Author Information

Author(s): Horthongkham Navin, Srihtrakul Tananun, Athipanyasilp Niracha, Siritantikorn Sontana, Kantakamalakul Wannee, Poovorawan Yong, Sutthent Ruengpung

Primary Institution: Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Hypothesis

Can recombinant proteins from avian influenza H5N1 induce a specific antibody response in mice?

Conclusion

Recombinant proteins produced in mammalian cells induce a significantly higher antibody response compared to those produced in E. coli.

Supporting Evidence

  • The HA and NS recombinant proteins produced in COS-7 cells induced significantly higher antibody titers than those produced in E. coli.
  • Immunization with 250 μg of recombinant proteins showed the best antibody response.
  • The study demonstrated that the recombinant proteins could neutralize heterologous avian influenza virus.

Takeaway

Scientists made a vaccine from bird flu proteins and tested it on mice to see if it could help them fight the virus.

Methodology

Mice were immunized with recombinant proteins at various doses, and antibody responses were measured using ELISA and neutralization assays.

Limitations

The study primarily focused on in vitro responses and did not include long-term efficacy or safety assessments in live animals.

Participant Demographics

Female Balb/c mice, 6 to 8 weeks old.

Statistical Information

P-Value

0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-8518-5-10

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication